|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 63.5 PLN | -0.47% |
|
-0.47% | -29.44% |
| May. 29 | Bioceltix S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 26 | Bioceltix S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Bioceltix S.A. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was PLN 2.63 million compared to PLN 1.44 million a year ago. Basic loss per share from continuing operations was PLN 0.74 compared to PLN 0.44 a year ago.
Diluted loss per share from continuing operations was PLN 0.74 compared to PLN 0.44 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -29.44% | 66.27M | |
| -11.35% | 79.83B | |
| -4.56% | 7.03B | |
| +21.00% | 3.57B | |
| +0.42% | 3.27B | |
| -7.81% | 1.21B | |
| -36.21% | 1.06B | |
| -38.70% | 1.02B | |
| -32.68% | 877M | |
| -18.12% | 854M |
BIOCELTIX S.A. 
